Korro Bio (KRRO) Invested Capital (2021 - 2023)
Korro Bio's (KRRO) quarterly Invested Capital came in at $11.7 million in Q1 2023, up 250.05% YoY from $3.3 million in Q1 2022, and up 16.67% on a QoQ basis from $10.0 million in Q4 2022.
Korro Bio (KRRO) Invested Capital (2021 - 2023) Analysis & Trends
Korro Bio (KRRO) has 3 years of Invested Capital data on file, last reported at $11.7 million in Q1 2023.
- Quarterly Invested Capital rose 250.05% year-over-year to $11.7 million in Q1 2023, while the trailing twelve-month figure through Dec 2023 was $11.7 million (down 57.57% YoY) and the FY2022 annual result came in at $10.0 million, up 1100.48% from the prior year.
- Invested Capital advanced to $11.7 million in Q1 2023, from $10.0 million in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $11.7 million in Q1 2023 to a low of $833000.0 in Q4 2021.
- A 3-year average of $6.7 million and a median of $7.1 million in 2022 frame the typical range for Invested Capital.
- Annual changes were most pronounced in 2022 — Invested Capital jumped 1100.48% — and 2023, when it surged 250.05%.
- Tracing KRRO's Invested Capital over 3 years: stood at $833000.0 in 2021, then jumped by 1100.48% to $10.0 million in 2022, then advanced by 16.67% to $11.7 million in 2023.
- The last three Invested Capital figures came in at $11.7 million (Q1 2023), $10.0 million (Q4 2022), and $8.3 million (Q3 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 190.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.45 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 380.00 Mn |
| 10 | Korro Bio | 231.77 Mn | 116.73 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 11.67 Mn |
| Dec 31, 2022 | 10.00 Mn |
| Sep 30, 2022 | 8.33 Mn |
| Jun 30, 2022 | 5.83 Mn |
| Mar 31, 2022 | 3.33 Mn |
| Dec 31, 2021 | 833,000.00 |